been questioned in video thoracoscopic surgery (VATS) since its description. Recently some authors published lower pN1 upstaging incidence after VATS resection compared to open thoracotomy. We want to evaluate the rate of upstaging in our centre after starting a VATS program. Method: All patient who required an anatomical resection for non-small cell lung cancer (NSCL) in our department have been retrospectively reviewed. Patients were divided in two groups in relation of the performed surgical approach, thoracotomy (THO) and VATS. Both groups were compared in terms of gender, age, smoking history, comorbidities, lung function, histology, clinical stage and tumour location. Rate of hilar lymph node upstaging (pN1) and mediastinal lymph node upstaging (pN2) were compared between both groups. Univariate and multivariate analysis was performed to identify independent risk factors for pN1 upstaging. Overall survival was compared between both techniques in pN0 patients. Result: Between January 2011 and October 2017, 1.081 lung resections were carried out in our centre. 323 of those were anatomical resections for early stage ( IIB) non-small cell lung cancer (NSCLC). There were no differences among groups except for FEV1, previous history of Diabetes Mellitus, tumour size and location (p<0.05). pN1 ratio was 20,5% in THO vs. 8,6% in VATS (p < 0,05) when performed accesses was compared. No differences were observed regarding pN2 upstaging (6% in THO and 6,5% in VATS; p>0,05). Only gender and centrality were identified as independent risk factors for hiliar lymph node upstaging in a multivariate analysis. For those patient with no upstaging (pN0) there were no survival differences comparing open and VATS approaches. Conclusion: In our series pN1 upstaging is less frequent in VATS than in open surgery. When analysed, tumour centrality has shown to be an independent risk factor for hilar upstaging. Additionally central tumours were much more prevalent in open surgery group. In conclusion, lower incidence of unnoticed pN1 in VATS surgery could be related to a selection bias, because thoracotomy was preferred when tumour considered central. Furthermore, the fact that no differences on survival in pN0 patients were detected suggests that no patients have been underdiagnosed and in consequence undertreated.
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October 2018 Abstracts S841 Background: As a preoperative marking of small pulmonary nodules, we developed Virtual Assisted Lung Mapping (VAL-MAP), which is consisted of preoperative simulation using three-dimensional CT images and transbronchial dye marking using indigocarmine (IC). Between 2012 and 2016, we performed VAL-MAP in more than 200 cases in a single institution; however, we sometimes came across a situation, in which an identification of marked IC was difficult at post-marking CT and/or during surgery. Herein, we have developed a new VAL-MAP (ICG-VAL-MAP) using indocyanine green (ICG) and contrast agent. The purpose of this study was to prospectively evaluate the visibility of newly-developed ICG-VAL-MAP in an identification of ICG at post-marking CT and during surgery. Method: Since January in 2017, we have performed ICG-VAL-MAP, using ICG and contrast agent in addition to IC as a marker, in 48 patients. During surgery, fluorescence endoscope system was used for identification of marked ICG. Result: Targeted lesions were 61 nodules with the diameter ranging from 2 to 38 mm (median 8 mm). The depth from the pleural surface ranged from 0 to 35 mm (median 8 mm). Total marked numbers were 122 (IC: 37, ICG: 85). At postmarked CT, IC was easily identified in 28 markings (76%), difficult to be identified in 5 (13%), unable to be identified in 4 (11%). On the other hand, ICG was easily identified in all markings. During surgery, IC was easily identified in 29 markings (78%), slightly identified in 4 (11%), unable to be identified in 4 (11%). On the other hand, ICG was easily identified in 84 markings (99%). Only in 1 case, ICG marking was accidentally placed far from a pleural surface, but ICG was slightly identified in a collapsed lung during surgery. There were no severe complications related to ICG-VAL-MAP. All nodules were diagnosed intraoperatively and an appropriate sublobar resection was performed in each patient. In all cases, surgeons were very much satisfied with ICG-VAL-MAP. In details, ICG-VAL-MAP was indispensable for resection of the targeted lesions in 17 cases (35%), and it was helpful for resecting the targeted lesion confidently in 30 cases (63%).
However, only in 1 case, ICG-VL-MAP was thought to be unnecessary (2% . Although postoperative mortality rates were not different between the two groups (0.8% vs. 0.8%, p¼1.0), postoperative complication rate was significantly lower in the group S (11.2% vs. 19.2%, P¼0.02). Especially, pulmonary complication rate including pneumonia, ARDS, and prolonged air leakage was significantly lower in the group S (2.5% vs. 8.3%, p<0.01). Postoperative decrease of diffusion capacity (DLco) was significantly lower in the group S (13.1% ± 16.4 vs. 18.2% ± 19.7, P¼0.02). Recurrence-free survival (RFS) and overall survival (OS) were not significantly different between patients who underwent lobectomy (5-year RFS, 84.0%; 5-year OS, 90.2%) and segmentectomy (5-year RFS, 89.0%; 5year OS 88.4%). (Figure 1 ) Conclusion: Thoracoscopic segmentectomy could achieve excellent early surgical outcomes with lower complication rates and preserved pulmonary function compared to lobectomy without jeopardizing long-term oncologic outcomes. Keywords: lung cancer, segmentectomy, lobectomy
